Whole-genome sequencing blood test spots lung cancer recurrence before imaging
Start here
A study published in The Journal of Molecular Diagnostics reports that a liquid biopsy based on whole-genome sequencing can detect circulating tumor DNA in the blood of patients with early-stage non-small cell lung cancer months before imaging can. The approach is intended to predict postoperative recurrence, offering a window in which recurrent disease could be flagged and potentially treated earlier than current scan-based follow-up allows. The findings come from a single published study; the test is not yet an established part of clinical care, and questions such as which patients benefit most, how results should change management after surgery, and how the method performs in broader validation remain open.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- Medical XpressPickNovel blood test detects lung cancer traces long before scans
A study published in The Journal of Molecular Diagnostics shows that WGS-based liquid biopsy can detect circulating tumor DNA in the blood of early-stage non-small-cell lung cancer months before imaging, to predict post-surgical recurrence.
Coverage and heat for this story
Reports so far 1·Heat now 6·Peak heat 10 (Oct 20 22:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.